Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eyenovia Inc (EYEN)  
$1.01 0.07 (7.74%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 24,880,000
Market Cap: 25.13(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.5165 - $5.01
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eyenovia is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its microdose array print (MAP™) platform technology, branded the Optejet®. MicroPine is Co.'s topical therapy for the treatment of progressive myopia, a back-of-the-eye ocular disease associated with pathologic axial elongation and sclero-retinal stretching. MicroLine is Co.'s pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens that causes the gradual loss of the eye's ability to focus on near objects and impairs near visual acuity. Mydcombi™ is Co.'s fixed combination formulation of tropicamide-phenylephrine for mydriasis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 160,717 165,607 357,711 630,255
Total Buy Value $176,411 $183,061 $635,654 $1,128,089
Total People Bought 1 2 6 7
Total Buy Transactions 3 4 15 27
Total Shares Sold 0 0 4,000 234,000
Total Sell Value $0 $0 $13,560 $1,148,560
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 5
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 143
  Page 4 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Rowe Michael M Chief Operating Officer   •       –      –    2021-05-27 4 B $4.71 $6,594 D/D 1,400 2,800 2.74 19%     
   Grant Stuart M.   –       –       •   2021-04-20 4 B $4.70 $143,500 D/D 30,000 4,315,440 0.01 7%     
   Grant Stuart M.   –       –       •   2021-04-19 4 B $4.86 $150,163 D/D 30,692 4,285,440 0.01 -2%     
   Haller Julia A Director   –       •      –    2021-03-31 4 A $0.00 $0 D/D 1,223 1,223     -
   Grant Stuart M.   –       –       •   2021-03-05 4 B $5.50 $192,500 D/D 35,000 4,254,748 0.01 -17%     
   Mario Ernest Director   –       •      –    2021-01-15 4 OE $2.27 $93,560 D/D 41,216 375,743     -
   Ianchulev Tsontcho Chief Executive Officer   •       •      –    2021-01-05 4 OE $2.27 $93,560 D/D 41,216 549,895     -
   Labelle Curt H Director   –       •      –    2020-11-20 4 D $0.00 $0 I/I (453,333) 0     -
   Ianchulev Tsontcho Chief Executive Officer   •       •      –    2020-11-20 4 D $0.00 $0 I/I (453,333) 0     -
   Gandolfo John P Chief Financial Officer   •       –      –    2020-11-19 4 B $3.40 $13,600 D/D 4,000 6,000 2.74 51%     
   Grant Stuart M.   –       –       •   2020-10-12 4 B $3.50 $355,000 D/D 100,000 4,219,748 0.01 92%     
   Grant Stuart M.   –       –       •   2020-09-24 4 B $2.98 $224,500 D/D 75,000 4,119,748 0.01 119%     
   Clasby Jennifer G VP, Clinical Operations   •       –      –    2020-09-18 4 OE $1.95 $52,137 D/D 26,737 55,702     -
   Eshelman Fredric N Director   –       •      –    2020-09-11 4 A $0.00 $0 D/D 7,288 1,292,787     -
   Mather Charles E Iv Director   –       •      –    2020-09-11 4 A $0.00 $0 D/D 7,288 23,359     -
   Lee Kenneth B Jr Director   –       •      –    2020-09-11 4 A $0.00 $0 D/D 7,288 19,359     -
   Sun Anthony Y Director   –       •      –    2020-09-11 4 A $0.00 $0 D/D 7,288 19,359     -
   Labelle Curt H Director   –       •      –    2020-09-11 4 A $0.00 $0 D/D 7,288 35,273     -
   Mario Ernest Director   –       •      –    2020-09-11 4 A $0.00 $0 D/D 7,288 334,527     -
   Grant Stuart M.   –       –       •   2020-08-20 4 B $2.06 $929,434 D/D 451,620 4,044,748 0.01 70%     
   Grant Stuart M.   –       –       •   2020-08-19 4 B $3.60 $1,198,800 D/D 333,000 3,593,128 0.01 62%     
   Mario Ernest Director   –       •      –    2020-03-24 4 B $2.27 $187,118 D/D 82,431 327,239 2.39 55%     
   Ianchulev Tsontcho Chief Executive Officer   •       •       •   2020-03-24 4 B $2.27 $187,118 D/D 82,431 508,679 3.23 55%     
   Grant Stuart M.   –       –       •   2020-03-23 4 B $2.06 $1,858,868 D/D 903,240 3,260,128 0.01 61%     
   Grant Stuart M.   –       –       •   2019-11-13 4 B $2.65 $26,500 D/D 10,000 2,356,888 0.01     -
  143 Records found
  1  2  3  4  5  6   
  Page 4 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us